The Parliamentary Committee on Health Visits TDRC
TDRC Director Dr Ray Handema, who is also the Principal Investigator of the SF2000 clinical trial explained that despite the phase 1 clinical trial results showing that SF2000SD was safe and tolerable, a phase 2 clinical trial meant to assess the efficacy of SF2000SD in HIV infected individuals could not proceed due budgetary constraints. Dr. […]